3. Crook H, Raza S, Nowell J, Young M, Edison P. Long covidmechanisms, risk factors, and management. BMJ 2021;374:n1648.
4. Soriano JB, Murthy S, Marshall JC, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 2022;22:e102-e107.
15. Baek G, Cha C. Symptom management of individuals with post-COVID-19 syndrome: a multiple-case study. J Korean Acad Fundam Nurs 2022;29:211-226.
24. Pérez-González A, Araújo-Ameijeiras A, Fernández-Villar A, et al. Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study. Sci Rep 2022;12:3369.
25. Song JY, Cheong HJ. Pneumococcal vaccine. J Korean Med Assoc 2014;57:780-788.
26. Cohen K, Ren S, Heath K, et al. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ 2022;376:e068414.
38. Han MK. How to prepare for a new pandemic? The Korean Academy of Science and Technology; 2021.
41. Tanne JH. Covid-19: BA.5 variant is now dominant in US as infections rise. BMJ 2022;378:o1770.